project id: TCGA-CHOL; case submitter id: TCGA-4G-AAZG; selected normal wgs: true; source center: 23; state: released; analyte type: DNA; analyte type id: D; spectrophotometer method: PicoGreen; age at index: 75; days to birth: -27490; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1936; age at diagnosis: 27490; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage III; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1716.0; icd 10 code: C22.1; last known disease status: not reported; morphology: 8160/3; primary diagnosis: Cholangiocarcinoma; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Intrahepatic bile duct; synchronous malignancy: Not Reported; tissue or organ of origin: Intrahepatic bile duct; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; days to collection: 1097; initial weight: 110.0; oct embedded: false; preservation method: Unknown; sample id: 5109b687-d275-49e1-9a64-9fe4f383385f; sample submitter id: TCGA-4G-AAZG-01A; portion id: 957131a8-f2af-4fc2-879a-d02fcfbbfb50; portion submitter id: TCGA-4G-AAZG-01A-11; slide id: 2831b8f1-9788-417c-8288-b105880e5f92; slide submitter id: TCGA-4G-AAZG-01A-01-TS1; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 80.0; percent tumor cells: 20.0; percent tumor nuclei: 80.0; section location: TOP;